Will a 1.4 x 7 mm stone at the left ureteropelvic junction pass with Flomax (tamsulosin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medical Expulsive Therapy for a 1.4 x 7 mm Stone at the Left Ureteropelvic Junction

Alpha-blockers like tamsulosin (Flomax) significantly increase the likelihood of spontaneous passage of a 1.4 x 7 mm stone at the ureteropelvic junction, with an expected absolute increase of 29% in stone passage rates compared to conservative management alone. 1

Stone Characteristics and Passage Probability

  • Size consideration:
    • At 7 mm length, this stone is in the moderate size range
    • For proximal ureteral stones <10 mm, spontaneous passage is possible but less likely than for smaller stones
    • Location at the ureteropelvic junction (proximal ureter) affects passage rates

Evidence for Medical Expulsive Therapy (MET)

  • Alpha-blockers are the preferred agents for MET 1, 2
  • Tamsulosin works by relaxing ureteral smooth muscle through alpha-1 receptor blockade 2
  • Meta-analysis shows:
    • 29% absolute increase in stone passage rates with alpha-blockers compared to controls (statistically significant) 1
    • Tamsulosin reduces stone passage time and limits pain 1, 2

Efficacy for Proximal Ureteral Stones

  • For proximal ureteral stones specifically:
    • Tamsulosin increased stone expulsion rate to 74.1% vs. 46.3% with conservative management alone 3
    • Mean time to stone passage was significantly shorter with tamsulosin (14.3 days vs. 19.6 days) 3
    • On multivariate analysis, tamsulosin was the only statistically significant predictor of stone expulsion (OR=3.198, p=0.021) 3

Treatment Algorithm

  1. First-line approach: Trial of tamsulosin 0.4 mg daily for up to 6 weeks

    • Monitor for stone passage
    • Provide appropriate pain management (NSAIDs preferred as first-line) 2
    • Ensure adequate hydration (>2L/day) 2
  2. If unsuccessful after 4-6 weeks:

    • Consider interventional approaches:
      • Ureteroscopy (URS) with laser lithotripsy - higher stone-free rates but slightly higher complication risk 1, 2
      • Shock Wave Lithotripsy (SWL) - 82% stone-free rate for proximal ureteral stones 2

Important Considerations

  • Monitor for signs of infection or complete obstruction requiring urgent intervention
  • Tamsulosin side effects are generally mild and transient 4
  • Maximum duration of conservative therapy should be limited to 6 weeks to avoid irreversible kidney injury 1
  • For patients with bleeding disorders or on anticoagulation, URS would be the preferred interventional approach if MET fails 1

Follow-up Recommendations

  • Urological follow-up within 1-2 weeks with imaging to assess stone position and progression 2
  • Patient education on warning signs requiring immediate medical attention:
    • Fever (sign of infection)
    • Uncontrolled pain
    • Persistent nausea/vomiting
    • Signs of urinary obstruction 2

In conclusion, tamsulosin is an effective medical expulsive therapy for a 1.4 x 7 mm stone at the ureteropelvic junction, significantly increasing the probability of spontaneous passage and reducing time to passage.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Ureteral Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.